Marshall Wace, LLP

SEC CIK: 0001318757
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overview All 13F holders of BMRN Full Q2 2026 holdings

Shares (Q2 2026): 97,300
Value: $5.57M
% of portfolio: <0.1%
Quarters held: 18; Since Q2 2021

Holdings of BMRN by Marshall Wace, LLP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	97,300	$5.57M	<0.1%	+97,300	New	Holders
Q1 2026	0	$0	0.0%	−310,891−100.0%	Sold out	Holders
Q4 2025	310,891	$18.5M	<0.1%	+310,891	New	Holders
Q3 2025	0	$0	0.0%	−83,852−100.0%	Sold out	Holders
Q2 2025	83,852	$4.61M	<0.1%	+69,515+484.9%	Added	Holders
Q1 2025	14,337	$1.01M	<0.1%	−666,257−97.9%	Reduced	Holders
Q4 2024	680,594	$44.7M	0.1%	+680,594	New	Holders
Q3 2024	0	$0	0.0%	−42,738−100.0%	Sold out	Holders
Q2 2024	42,738	$3.52M	<0.1%	−36,331−45.9%	Reduced	Holders
Q1 2024	79,069	$6.91M	<0.1%	−352,274−81.7%	Reduced	Holders
Q4 2023	431,343	$41.6M	0.1%	+223,656+107.7%	Added	Holders
Q3 2023	207,687	$18.4M	<0.1%	−7,635−3.5%	Reduced	Holders
Q2 2023	215,322	$18.7M	<0.1%	+200,309+1,334.2%	Added	Holders
Q1 2023	15,013	$1.46M	<0.1%	−585,259−97.5%	Reduced	Holders
Q4 2022	600,272	$62.1M	0.2%	+139,313+30.2%	Added	Holders
Q3 2022	460,959	$39.1M	0.1%	−127,659−21.7%	Reduced	Holders
Q2 2022	588,618	$48.8M	0.1%	+222,438+60.7%	Added	Holders
Q1 2022	366,180	$28.2M	0.1%	−263,254−41.8%	Reduced	Holders
Q4 2021	629,434	$55.6M	0.1%	+293,449+87.3%	Added	Holders
Q3 2021	335,985	$26.0M	0.1%	+295,034+720.5%	Added	Holders
Q2 2021	40,951	$3.42M	<0.1%	+40,951	New	Holders